Organizer/Speaker
- Daniel Geschwind, University of California Los Angeles, USA
 
                  Dr. Geschwind is the Gordon and Virginia MacDonald  Distinguished Professor of Neurology, Psychiatry and Human Genetics at UCLA. In  his capacity as Senior Associate Dean and Associate Vice Chancellor of  Precision Health, he leads the Institute for Precision Health (IPH) at UCLA. In  his laboratory, his group has pioneered the application of systems biology  methods in neurologic and psychiatric disease, with a focus on autism spectrum  disorders (ASD) and neurodegenerative conditions. His laboratory has made major  contributions to identifying genetic causes of autism spectrum disorder,  defining the molecular pathology of autism and allied psychiatric disorders,  and has worked to increase diversity in autism research. His work in dementia  is focused on the mechanisms of tauopathies, where his laboratory is developing  novel therapeutic approaches. He sits on editorial boards of Cell, Science and Neuron, and is among the highest cited neurologists in the world. He  has received several awards for his laboratory’s work including the American  Neurological Association (ANA) Derek Denny-Brown Neurological Scholar Award,  most recently the Society of Biological Psychiatry Gold Medal Award and the  American Academy of Neurology’s 2022 Cotzias Lecture and Award. He is the
                      2022 National Academy of Medicine recipient of the Rhoda and  Bernard Sarnat International Prize in Mental Health. He is an elected Member of  the American Association of Physicians and the National Academy of Medicine.
« Go Back